These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18426721)

  • 1. [Gaucher disease: importance of early diagnosis and therapy].
    Simon G; Erdos M; Maródi L; Tóth J
    Orv Hetil; 2008 Apr; 149(16):743-50. PubMed ID: 18426721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enzyme replacement therapy for Gaucher disease introduced in late adulthood].
    Juhász P; Tóth B; Maródi L; Erdos M
    Orv Hetil; 2012 Feb; 153(7):264-70. PubMed ID: 22318527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gaucher's disease: pathogenesis, diagnosis and therapy].
    Pregun I; Tulassay Z
    Orv Hetil; 2004 Sep; 145(37):1883-90. PubMed ID: 15493618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocerebrosidase (Gaucher disease).
    Beutler E; Gelbart T
    Hum Mutat; 1996; 8(3):207-13. PubMed ID: 8889578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and molecular characterization of adult patients with type I Gaucher disease and carrier frequency analysis of Leu444Pro - a common Gaucher disease mutation in India.
    Sheth J; Pancholi D; Mistri M; Nath P; Ankleshwaria C; Bhavsar R; Puri R; Phadke S; Sheth F
    BMC Med Genet; 2018 Oct; 19(1):178. PubMed ID: 30285649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gaucher disease--one of the possible causes of splenomegaly--case report].
    Sokołowska B; Skomra D; Czartoryska B; Tomczak W; Tylki-Szymańska A; Repelewska M; Drop A; Gromek T
    Pol Arch Med Wewn; 2004 Sep; 112(3):1107-12. PubMed ID: 15727093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gaucher's disease ].
    Belmatoug N; Caubel I; Stirnemann J; Billette de Villemeur T
    J Soc Biol; 2002; 196(2):141-9. PubMed ID: 12360743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme replacement therapy for Gaucher disease in Australia.
    Goldblatt J; Szer J; Fletcher JM; McGill J; Rowell JA; Wilson M
    Intern Med J; 2005 Mar; 35(3):156-61. PubMed ID: 15737135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.
    Charrow J; Andersson HC; Kaplan P; Kolodny EH; Mistry P; Pastores G; Prakash-Cheng A; Rosenbloom BE; Scott CR; Wappner RS; Weinreb NJ
    J Pediatr; 2004 Jan; 144(1):112-20. PubMed ID: 14722528
    [No Abstract]   [Full Text] [Related]  

  • 11. Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy.
    Burrow TA; Cohen MB; Bokulic R; Deutsch G; Choudhary A; Falcone RA; Grabowski GA
    J Pediatr; 2007 Feb; 150(2):202-6. PubMed ID: 17236903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme Replacement Therapy in a Gaucher Family.
    Erdem N; Buran T; Berber I; Aydogdu I
    J Natl Med Assoc; 2018 Aug; 110(4):330-333. PubMed ID: 30126557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaucher Disease: Clinical, Biological and Therapeutic Aspects.
    Dandana A; Ben Khelifa S; Chahed H; Miled A; Ferchichi S
    Pathobiology; 2016; 83(1):13-23. PubMed ID: 26588331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.
    Kaplan P; Andersson HC; Kacena KA; Yee JD
    Arch Pediatr Adolesc Med; 2006 Jun; 160(6):603-8. PubMed ID: 16754822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher disease.
    Mignot C; Gelot A; De Villemeur TB
    Handb Clin Neurol; 2013; 113():1709-15. PubMed ID: 23622393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry.
    Fairley C; Zimran A; Phillips M; Cizmarik M; Yee J; Weinreb N; Packman S
    J Inherit Metab Dis; 2008 Dec; 31(6):738-44. PubMed ID: 18979180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase.
    Rosenthal DI; Doppelt SH; Mankin HJ; Dambrosia JM; Xavier RJ; McKusick KA; Rosen BR; Baker J; Niklason LT; Hill SC
    Pediatrics; 1995 Oct; 96(4 Pt 1):629-37. PubMed ID: 7567322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline characteristics and outcome in Romanian patients with Gaucher disease type 1.
    Grigorescu-Sido P; Drugan C; Alkhzouz C; Zimmermann A; Coldea C; Denes C; Grigorescu MD; Cret V; Bucerzan S
    Eur J Intern Med; 2010 Apr; 21(2):104-13. PubMed ID: 20206881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
    Choy FY; Zhang W; Shi HP; Zay A; Campbell T; Tang N; Ferreira P
    Blood Cells Mol Dis; 2007; 38(3):287-93. PubMed ID: 17196853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gaucher disease type 1--therapeutic results of enzyme substitution].
    Steensberg J; Nielsen KG; Brandt NJ
    Ugeskr Laeger; 1998 Jun; 160(26):3929-30. PubMed ID: 9656836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.